Work

Gaining trust through transparency: the EMERGENT-2 trial – Authors' reply

Year: 2024

Type: letter

Source: The Lancet

DOI: 10.1016/s0140-6736(24)01269-8

Authors: Inder Kaul, Alan Breier, Andrew C Miller, Steven M Paul, Stephen K Brannan

Institutions: Bristol-Myers Squibb (United States), Indiana University School of Medicine

Language: English

Topic: Pharmaceutical industry and healthcare

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4401409220

Cites: 1

Cited by: 1

Related to: 10